Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
Diego Chowell, Luc G.T. Morris, Claud M. Grigg, Jeffrey K. Weber, Robert M. Samstein, Vladimir Makarov, Fengshen Kuo, Sviatoslav M. Kendall, David Requena, Nadeem Riaz, Benjamin D. Greenbaum, James Carroll, Edward B. Garon, David Michael Hyman, Ahmet Zehir, David B. Solit, Michael F. Berger, Ruhong Zhou, Naiyer A. Rizvi, Timothy An-thy Chan
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1126/science.aao4572
- Published
- Dec 7, 2017
- Venue
- Science
- DOI
- 10.1126/science.aao4572
- PubMed
- 29217585
- Categories
- Cancer Immunotherapy and Biomarkers
- Provenance
- openalex